Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
Which Film Has the Incomparable Melodic Score?- ‘Democratizing space’ is more than just adding new players – it comes with questions around sustainability and sovereignty
- Vote In favor of Your Favored Language Interpretation Administration
- Germany raises prospect of military forces to secure Ukraine peace
- The 15 Best Business visionaries Under 40
- Best Veggie lover Dinner: What's Your Plant-Based Pick?
- Which Breakfast Enraptures Your Taste Buds? Vote
- Fundamental Venture The board Apparatuses for Remote Groups
- What is colostrum? And should you be taking it?
